Best deals on stocks bonds By Carla Fried @Money April

New Post Public Reply Private Reply Replies (0) Message Board
Stock Buff

Best deals on stocks & bonds

@Money April 23, 2012: 10:31 AM ET

Very little in the world of investments is a true bargain these days, but you can still find pockets of good value in stocks and bonds.

Very little in the world of investments is a true bargain these days, but you can still find pockets of good value in stocks and bonds.

(Money Magazine) -- It's getting tough to find a bargain these days and the stock market isn't cheap. But there's value to be found in the markets, if you tilt your game plan toward equities.

To assess the relative value of stocks and bonds, experts look at the earnings yield on stocks (that is, earnings per share divided by price) vs. the yield of a 10-year Treasury; when that gap is wide, stocks are the better deal.

Today's 7.5 percentage point spread is historically very high, says Alec Young, global equity strategist at S&P Capital IQ. "That's telling you stocks are definitely the better long-term value," he says.

If your portfolio has gotten a bit bond-heavy over the past few years, shift some money back into stocks.

Go big. Really big. Some of the best values right now are the largest companies, typically with stock market values north of $100 billion.

According to the Leuthold Group, the 50 largest multinationals trade at a price/earnings multiple (based on 2012 profit estimates) of 11.6.

That's well below the 15.6 average P/E for the next 2,000 largest stocks.

"You can buy world-class companies in this group at Wal-Mart prices," says George Sertl, a co-manager of Artisan Value fund.

His picks:

Apple ( AAPL , Fortune 500 ) P/E: 12.2

Why: Supercharged growth potential and pristine balance sheet.

Oracle ( ORCL , Fortune 500 ) P/E: 11.2

Why: Is the dominant player in its industry; generates lots of cash.

Piggyback on corporate spending. Some of the best deals today are within the industrials sector, says Brad Sorensen, director of market and sector analysis at the Schwab Center for Financial Research.

Cash-rich companies will increase their spending on equipment and systems as the economy strengthens, and some of their stocks are still well-priced.

Morningstar analyst Adam Fleck points to these two:

Parker Hannifin ( PH , Fortune 500 ) P/E: 10.9

Why: This industrials equipment manufacturer should see a bump in business; smart operating practices have kept its margins fat.

Terex ( TEX , Fortune 500 ) P/E: 8.2

Why: Orders for aerial work platforms and cranes are picking up for this industrial equipment maker; the stock is cheap.

Go abroad for dividends . The equity market has been on a tear this year, yet stocks that don't pay out dividends have enjoyed the lion's share of those gains.

S&P Capital IQ's Alec Young expects returns for the rest of the year to come from dividend income. And he notes that yields abroad are significantly higher.

According to WisdomTree, three-quarters of 2011's payouts came from overseas firms.

Add a bit of junk. Rising Treasury yields recently beat down bond returns, but high-yield bonds are less sensitive to higher rates.

And while a slowing economy is kryptonite for junk, that possibility is looking less likely lately, says Anthony Valeri, investment strategist at LPL Financial. While non-investment-grade bonds have had a sizable rally from this past fall, "the 7% average yield is still compelling vs. what you can get anywhere else," says Valeri.

That said, junk is best sipped, not gulped: Limit your high-yield tasting to 10% or less of your bond portfolio.

What you don't know. The worst one-year return on Treasuries: -14.9%. In 2009 the yield on long-term Treasury bonds rose from 3.5% to 4.5%. While rising yields provide more income, the price of bonds falls when yields increase.

So not a deal. Utilities and REITs.

Sure, dividend yields of 4% or so are enticing, but many utilities are expensive, and as the economy gains steam, defensive stocks will fall further out of favor.

High-yielding real estate trusts, which manage a pool of commercial properties, recently traded at 17 times earnings vs. 13 for the S&P, says Tim Clift, chief investment strategist at Envestnet.

Plus, they'll suffer from higher financing costs when interest rates eventually rise.

4 expert picks

Todd Rosenbluth, ETF analyst at S&P Capital IQ picks these best ETF deals.

Vanguard Mega Cap ( MGC ) "With an annual expense ratio of 0.12% of assets, it's a cheap way to access the largest stocks."

IShares Russell 1000 ( IWF ) "This gives you exposure to cyclicals. Some 29% of this ETF is tied to IT stocks, 14% in consumer discretionary, and 13% in industrials. Eight of the top 10 largest positions are expected to outperform over the next 12 months."

Wisdomtree DEFA ( DWM ) "With a 4.2% yield, this international dividend ETF gives you a very diversified approach -- both in sector and in country allocations -- to developed international markets."

SPDR Barclays Capital High Yield Bond ( JNK ) "Paying a 0.40 expense ratio for a 7% yield is a smart way to get exposure to high-yield bonds."

Do you know a Money Hero? MONEY magazine is celebrating people, both famous and unsung, who have done extraordinary work to improve others' financial well-being. Nominate your Money Hero .   To top of page

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hartford Students Get Boost from Hygiene Initiatives

Updated Category News Views 2

Beyond Backpacks: Essential Hygiene for Hartford Kids When September rolls around, it’s not just about those shiny new backpacks and unopened notebooks. In good ol’ Hartford, some students find themselves in need of basics that get overlooked—a stick of deodorant, a bar of soap, maybe some period products. Skimp on these, and all of a sudden, showing up for school...

Continue Reading
Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
GoDaddy Faces Class Action: Investor Stakes High

Updated Category News Views 3

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 2

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
AARP New York Promotes Affordable 'Staycation' Experiences

Updated Category News Views 3

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 0

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 0

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Delisting Gray Wolf Sparks Heated Hunter Nation Debate

Updated Category News Views 2

Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...

Continue Reading

Top 5 Most Recently Viewed Articles

CLOU Unveils Innovative Water-Cooled Energy Storage Solutions

Updated Category News Views 108

CLOU Launches Aqua-E261 & Aqua-X261 Energy Storage Systems CLOU Electronics has made a significant mark in the energy sector by introducing its next-generation commercial and industrial (C&I) liquid-cooled energy storage systems, the Aqua-E261 and Aqua-X261, at a prominent solar energy expo. This reveals the company’s dedication to providing cutting-edge energy...

Continue Reading
Upcoming Earnings for Lands' End: What to Expect

Updated Category News Views 199

Upcoming Earnings for Lands' End: Insights and Expectations Lands' End (NASDAQ: LE) is on the cusp of releasing its latest quarterly earnings report. With anticipation brewing among investors, crucial insights into the company's financial health and future guidance are coming to light. Earnings Estimates and Market Reactions Analysts project that Lands' End may announce...

Continue Reading
Phagenesis Welcomes Chad Hoskins as New CEO to Drive Growth

Updated Category News Views 229

Phagenesis Welcomes Chad Hoskins as CEO Phagenesis, a pioneering company in the field of neurostimulation therapies, has announced a major leadership transition with the appointment of Chad Hoskins as Chief Executive Officer. This change comes on the heels of the company’s recent successes, including securing $42 million in Series D funding aimed at expanding the reach...

Continue Reading
Class Action Filed Against ASP Isotopes Inc. Over Misleading Claims

Updated Category News Views 229

Class Action Lawsuit Against ASP Isotopes Inc. Recently, Robbins LLP has informed investors about a class action that was filed against ASP Isotopes Inc. (NASDAQ: ASPI). This lawsuit involves individuals and entities who purchased or acquired securities related to ASP Isotopes during a specified period. The company is currently recognized as a development-stage firm that...

Continue Reading
TOMI Environmental Solutions Unveils Strategic Partnership Boost

Updated Category News Views 229

Exciting Partnership in Disinfection Solutions TOMI Environmental Solutions, Inc.® (NASDAQ: TOMZ), a leader in disinfection technologies, recently announced a significant OEM partnership with Pharma Biotech System Components LLC. This collaboration is set to elevate the effectiveness of TOMI's SteraMist Integrated System (SIS) through the integration of innovative...

Continue Reading